2015
DOI: 10.2323/jgam.61.177
|View full text |Cite
|
Sign up to set email alerts
|

Study on <i>in vivo</i> effects of bacterial histidine kinase inhibitor, Waldiomycin, in <i>Bacillus subtilis</i> and <i>Staphylococcus aureus</i>

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 18 publications
(10 citation statements)
references
References 38 publications
0
8
0
Order By: Relevance
“…Despite this general attitude, there has been certain progress in harnessing bacterial signalling systems to elicit favourable responses. The natural inclination is to search for compounds such as (waldiomycin and signermycin B) that target the essential genes involved in signal transduction, e.g., (in Gram-positive bacteria) histidine kinase WalK (YycG), and to measure success by the efficiency of killing B. subtilis, Staphylococcus aureus and Streptococcus mutans (Watanabe et al, 2012;Fakhruzzaman et al, 2015). However, managingor even preventingdisease does not necessarily require eradication of the bacteria.…”
mentioning
confidence: 99%
“…Despite this general attitude, there has been certain progress in harnessing bacterial signalling systems to elicit favourable responses. The natural inclination is to search for compounds such as (waldiomycin and signermycin B) that target the essential genes involved in signal transduction, e.g., (in Gram-positive bacteria) histidine kinase WalK (YycG), and to measure success by the efficiency of killing B. subtilis, Staphylococcus aureus and Streptococcus mutans (Watanabe et al, 2012;Fakhruzzaman et al, 2015). However, managingor even preventingdisease does not necessarily require eradication of the bacteria.…”
mentioning
confidence: 99%
“…Identification of compounds that inhibit the activity of two component systems has been mooted as a potential path to find new antibiotics (see for example, Desnottes, 1996;Matsushita and Janda, 2002;Watanabe et al, 2008;Gotoh et al, 2010;Bem et al, 2015). Indeed, one such compound, waldiomycin, which was identified from a screen for kinase inhibitors, has been proposed as a potential treatment of Gram-positive bacterial infections (Igarashi et al, 2013;Fakhruzzaman et al, 2015;Eguchi et al, 2017). Other examples of identified TCS inhibitors are given in Bem et al (2015).…”
Section: Discussionmentioning
confidence: 99%
“…This motif was further supported by the observation that waldiomycin inhibited other HKs such as ResE and PhoR, which share the characteristic residues in the H-box region with WalK, with comparable IC 50 s. To a lesser extent, waldiomycin also inhibited CitS, which is segregated from the WalK cluster in the phylogenetic analysis of the H-box region sequences of HKs in B. subtilis. Previously, we reported the IC 50 s of waldiomycin against the WalK HKs of B. subtilis, S. aureus, E. faecalis, and Streptococcus mutans (Fakhruzzaman et al, 2015;Igarashi et al, 2013) and showed that waldiomycin is a general WalK inhibitor. In this study, the target of waldiomycin was extended from WalK to other HKs in B. subtilis.…”
Section: Waldiomycin Inhibits Multiple B Subtilis Hks In Vitromentioning
confidence: 99%
“…The extraction of total RNA from B. subtilis 168 and its mutant strains (R377M/R378M/S385A and R377M/R378M/R389M), cultured in the presence or absence of waldiomycin and qRT-PCR, were performed as previously described (Fakhruzzaman et al, 2015). The primers used for qRT-PCR are listed in Table 3.…”
Section: Extraction Of Total Rna and Qrt-pcrmentioning
confidence: 99%
See 1 more Smart Citation